The pp32 (ANP32A) gene acts as a tumor suppressor while its closely related homologue pp32r1 (ANP32C) is oncogenic and is overexpressed in breast, prostate and pancreatic tumors. The transduction of p53wt cell lines (ACHN and HeLa) with pp32r1 or pp32r1Y140H lentivirus increased the proliferation of p53wt cell lines compared to the untransduced control cells while transduction of the p53 R248W MiaPaCa2 cell line had no effect. Cell cycle analysis of transduced ACHN cells by PI staining and BrdU incorporation illustrated a pronounced shift toward the S-phase of the cell cycle in cells overexpressing the pp32r1 and pp32r1Y140H proteins. Confocal microscopy and western blotting demonstrated that pp32r1 and the pp32r1Y140H mutant protein reside predominantly in the cytoplasm in constrast to pp32 which is a nuclear/cytoplasmic shuttling protein. To determine the effects of pp32r1 or pp32r1Y140H overexpression at the proteomic level we performed a comprehensive proteome analysis on ACHN, ACHN-pp32r1 and ACHN-pp32r1Y140H cell lysates using the isotope-coded protein label (ICPL) method. Among those proteins with > 40% regulation were Macrophage Capping protein (CAPG) and Chromodomain Helicase DNA binding protein 4 (CHD4) proteins which were significantly upregulated by pp32r1 and pp32r1Y140H overexpression. This increase in CHD4 also appears to influence a number of cell cycle regulator genes including; p53, p21 and cyclinD1 as judged by western blotting. Silencing of CHD4 in ACHN-pp32r1Y140H cells using specific shRNA reverted the cell cycle dysregulation caused by pp32r1Y140H expression to that of the untransduced ACHN cell line, suggesting that CHD4 is the prominant effector of the pp32r1/ pp32r1Y140H phenotype.
Introduction
Pp32 (ANP32A) is a well characterized multifunctional protein that regulates transcription, apoptosis and cell cycle progression through the Inhibitor of Acetyl Transferase activity (INHAT), SET and Retinoblastoma protein (pRb) complexes that all contain pp32 [1, 2] . While pp32 itself acts as a tumor suppressor its close homologue pp32r1 (ANP32C) is oncogenic and found to be overexpressed in poorly differentiated tumors, but not in normal cells [3, 4] .
Interestingly, pp32r1 has also been suggested to be highly expressed in activated stem cells including mobilized CD34 + peripheral blood cells and CD34 + cord blood cells but not in resting CD34 + bone marrow cells [3] . The functional role of pp32r1 at present is unclear and despite the high sequence homology between pp32 and pp32r1 (~87%), pp32r1 is unable to substitute for pp32 in some situations as is demonstrated by its inability to associate with retinoblastoma protein [2] . Some functionality 'sharing' however is likely to occur between the pp32 family members (ANP32A-H) [4] since pp32 knockout mice have no distinct phenotype [5] .
Structurally the 28-kDa pp32 family of proteins contain several functional domains; a capped LRR motif at the N-terminus [6] a central domain (amino acids 150-174) containing the region required for cellular transformation [7] and a highly acidic C terminus containing~70% aspartic and glutamic acid residues [8] . A functional mutation in pp32r1 comprising a Y140H substitution has been characterized and is associated with the rapid growth of the prostate cancer cell line PC-3 from where it was identified, furthermore transfection of this mutated gene construct into cell lines demonstrated striking increases on cell proliferation rates [3] .
In this work we sought to further characterize the effects of pp32r1 and the pp32r1Y140H functional mutant in cells and investigate the mechanism by which it dysregulates the cell cycle.
Materials and methods

Lentiviral vector constructs
Genomic DNA was isolated from~5 × 10 6 HeLa cells using a Nucleospin genomic DNA isolation kit (Machery-Nagel). A 1 Kb pp32r1 (PP32R1) genomic fragment was amplified by PCR using this genomic DNA as the template. The pp32r1 ORF was then amplified using specific primers using the gemomic PCR fragment as a template and the resulting 702 bp PCR product was ligated in the eukaryotic expression vector pcDNA3.1 V5/His TOPO (Invitrogen, Karlsruhe, Germany). A lentiviral vector construct was then generated by subcloning the BamHI/XbaI fragment of the pcDNA3.1-pp32r1-V5HIS construct into the lentiviral pRRL.PPT.SFFV.mcs.pre vector [9] to generate pRRL-pp32r1-V5HIS.
The pRRL-pp32r1Y140H-V5HIS mutant construct was generated using the Quickchange mutagenesis kit (Stratagene) according to the manufacturers protocol using the following oligonucleotide sequences; Y140H_sense 5′-ttctcctgcaactcacacatctcgacagctgttac-3′, Y140H_antisense 5′-gtaacagctgtcgagatgtgtgagttgcaggagaa-3′. Wild type and mutant constructs were both sequence verified using an ABI PRISM 377 sequencer (Applied Biosystems, Foster City, CA, USA).
Virus production in HEK293T cells
HEK293T cells were transfected essentially as described [10] with 5 μg Plasmid DNA (packaging plasmid: psPAX2; envelope plasmid: pDM2G) in DMEM media (Invitrogen) using Lipofectamine (Invitrogen). Transfected HEK293T cells were incubated for 24 h before replacing the cell culture media. 48 h post-transfection, virus-containing supernatant was removed, passed through a 0.45 μm filter (Millipore GmbH, Schwalbach, Germany) and centrifuged for~12 h (16°C, 10.000 rpm). The Lentiviral-pellet was then dissolved in DMEM (Invitrogen) and used directly for transduction.
Cell culture, lentiviral transduction and cell growth assays
ACHN, Hela and MiaPaCa2 cells were grown at 37°C in a 5% CO2-humidified atmosphere in Dulbecco's modified Eagle's medium (DMEM) supplemented with 50 U/mL penicillin, 50 μg/mL streptomycin, 2 mM L-glutamine, 1% NEAA, 1 mM Sodium Pyruvate and 10% fetal bovine serum (FBS). For lentiviral transduction 5 × 10 6 cells were plated in 10-cm tissue culture plates. The following day transduction of cells was then performed by adding the dissolved lentiviral-pellet to the cells in the presence of 8 μg/mL protamine sulfate (Sigma-Aldrich) followed by incubation for 8 h. Control pRRL-GFP lentiviral particles were used to monitor the transduction efficiency for the various cell types.
For cell growth assays 5 × 10 5 cells were plated in 10-cm tissue culture plates and incubated for 6 days. Cells were then fixed and stained with a solution of 0.2% methylene blue in 50% methanol.
Evaluation of pp32 and pp32r1 mRNA levels by real-time RT-PCR
Total cellular RNA was isolated from cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany), those samples used to measure pp32r1 gene expression levels were treated with DNase to prevent genomic amplification since pp32r1 is an intronless gene. RNA (1 μg) was transcribed into cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer's protocol. qRT-PCR using the appropriate specific TaqMan assay kit ( Supplementary Table 1 , Applied Biosystems, Darmstadt, Germany) was carried out on a StepOne Plus Real-Time PCR System (Applied Biosystems) with thermal cycling conditions of 50°C for 2 min and 95°C for 10 min followed by 40 cycles at 95°C for 15 seconds and 60°C for 1 min. GAPDH or β-actin mRNA (as specified) was amplified as a reference standard for normalization of mRNA levels and all reactions were performed in triplicate. The Relative C T Method (described in the User Bulletin No. 2, ABI PRISM 7700 Sequence Detection System, pp. [11] [12] [13] [14] [15] as implemented in the steponeplus software was used to calculate the relative mRNA level of the assay gene normalized to GAPDH or β-actin in each sample. All values are expressed as fold-changes relative to their appropriate control (set to 1.0).
Transfection of cells with shRNA
Cells were plated into 6 well plates in 2 ml culture media at cell numbers to achieve 50-70% confluency the next day. Transfections were carried out using Lipofectamine 2000 reagent (Invitrogen) as per the manufacturer's protocol. CHD4 shRNAs were from OriGenevector control, scrambled shRNA (scr) control, shRNA#1, shRNA#2, shRNA#3 and shRNA#4. The highest knockdown efficiency was seen with shRNA#1 and shRNA#1 + #2 combined and these were selected for further studies.
Confocal Laser Scanning Microscopy (CLSM)
HEK293T cells were plated on coverslips in 6 well plates and transfected with pcDNA3.1⁄CT-GFP-TOPO (Invitrogen) containing pp32r1-GFP and pp32r1Y140H-GFP. 72 h post transfection cells were fixed with 4% p-formaldehyde, stained with the nuclear stain DAPI and imaged on a Leica DMIRE2 system using 405 nm and 488 nm laser lines. Bright field images were simultaneously acquired. All images were acquired with 63X oil immersion lens, zoom 3.00 and processed using Image J software.
SDS-PAGE/Western blotting
Whole cell lysates were obtained using RIPA lysis buffer containing Na 2 VO 3 and NaF (when specified) Protein quantitation was performed using a BCA assay (Uptima). For Nuclear/Cytoplasmic localization experiments cells were lysed using the ProteoJet cytoplasmic and nuclear protein extraction kit (Fermentas) according to the manufacturer's protocol. Proteins were separated using 4%-12% Bis-Tris polyacrylamide gels (Invitrogen) and were transferred to PVDF membrane using an iBlot (Invitrogen) before blocking and incubation with specific antibodies (Supplementary Table 2 ).
Cell cycle analysis
The cell cycle distribution of the three cell lines was analyzed by using propidium iodide (PI)-staining. Briefly, 1 × 10 6 cells were trypsinized and washed with PBS and permeabilized with 70% ethanol. Cells were washed again with PBS and then stained with, 200 mg/mL RNase A (Sigma) and 50 mg/mL propidium iodide (Sigma) before analysis on a FACSCanto flow cytometer (BD bioscience). Single cell populations were gated, as judged by PI-A vs PI-W, and the percentage of cells in the various stages of the cell cycle was determined using Flowjo (Treestar, Inc) implementing the Watson (pragmatic) model. Three independent experiments were performed for each cell line, a representative of which is shown.
S phase analysis
BrdU incorporation assay (BrdU-FITC/7-AAD kit, Becton Dickinson) was performed on all 3 cell lines according to the manufacturer's protocol. Cells were incubated with 10 μM BrdU for 30 min. Labeled cells were harvested, fixed, permeabilized, neutralized and BrdU detected using a FITC labeled mouse anti-BrdU antibody. Cells were then resuspended in the presence of 7-AAD and BrdU incorporation/DNA content were analyzed using a FACSCanto flow cytometer (BD bioscience). 2-D cell cycle analysis (FITC Vs 7-AAD) was carried out using Flowjo (Treestar, Inc).
ICPL
ICPL labelling and mass spectrometry was carried out by Toplab GmbH (Martinsfried, Germany) using the protocol as described by [11] . A total of 1-2×10 6 ACHN, ACHN-pp32r1 transduced, and ACHN-pp32r1Y140H transduced cells were harvested from 70% confluent plates and washed thoroughly with PBS. Cells were then lysed and equal protein amounts for the three different samples were labeled with ICPL triplex, and multiplexed. The SERVA protein standard composed of three proteins in known ratios was added to control the label efficiency. The samples were then reduced, alkylated, cleaved with trypsin and GluC, and analyzed by high resolution LC-ESI-MS/MS using an LTQ-Orbitrap (Thermo Scientific). The acquired MS/MS spectra were then searched against the human Swiss-Prot and the NCBI databases using MASCOT [12] .
Database queries were performed using Mascot software [12] implementing the IPI human and the respective decoy databases.
After the first LC-ESI-MS/MS run an inclusion list of unidentified regulated proteins was generated and used for a second LC-ESI-MS/ MS run to increase the number of identified regulated proteins. Data evaluation, interpretation, and quantification were performed using the ICPLQuant software (MPI for Biochemistry) [13] that sums the two LC-MS/MS runs for the experiment. Additionally we performed a reference set sample where equal amounts of each of the three samples were pooled together, then split into three equal aliquots and labelled with the light, medium, and heavy ICPL label, respectively, this enables detection of all triplets possible and was included in the subsequent ICPL Quant data analysis.
Results
Generation of cancer cell lines overexpressing pp32r1 or pp32r1Y140H mutant proteins
The renal cancer cell line ACHN, cervical cancer cell line HeLa and pancreatic cancer cell line MiaPaCa2 were lentivirally transduced with constructs encoding either pp32r1 or the pp32r1Y140H functional mutant as described in the materials and methods. Stable cell lines were then generated by limiting dilution with selection based upon protein expression as judged by western blotting against the V5 epitope tag on the recombinant pp32r1 proteins. The various cloned cell lines showed high expression of pp32r1 and pp32r1Y140H proteins as illustrated in Fig. 1a . These cell lines were subsequently used in all additional experiments.
Characterization of the cell growth and cell cycle modulation in pp32r1 and pp32r1Y140H overexpressing cancer cell lines
We observed as was previously described [3] that pp32r1Y140H expressing ACHN cells grew much faster compared to ACHN or pp32r1 expressing cells. To visualize the differences in proliferation rates of the transduced ACHN, HeLa and MiaPaCa2 cell lines we plated them out at low confluency (5 × 10 5 cells per 10 cm dish) and grew them for 6 days before fixing and staining with methylene blue. While the p53 wt cell lines (ACHN and HeLa) demonstrated pronounced increases in proliferation upon overexpression of pp32r1 or pp32r1Y140H mutant proteins the transduced p53 R248W MiaPaCa2 cell line showed no differences in cell growth ( Fig. 1b) .
To further investigate this phenomenon we performed comparative cell cycle analysis on the ACHN cell lines using propidium iodide (PI) staining. Control ACHN cells showed a cell cycle distribution containing 13.7% of cells in the S-phase of the cell cycle, while cells transduced with pp32r1 or the Y140H mutant showed 15.4% and 24.2% respectively in the S-phase of the cell cycle ( Fig. 2a ,c,e). To confirm these results a BrdU incorporation assay was performed and these results are illustrated in Fig. 2b , d, f, while Supplementary Table 3 summarizes the results of both Cell cycle and S phase analysis.
In both experiments we observed a 2-fold increase in S phase of pp32r1Y140H expressing ACHN cells relative to ACHN and pp32r1 expressing cells, reflecting the increased proliferation rate in these cells.
Control HeLa cells showed a cell cycle distribution containing 12.4% of cells in the S-phase of the cell cycle, while cells transduced with pp32r1 or the Y140H mutant showed increases to 13.2% and 16.2% respectively in the S-phase of the cell cycle ( Supplementary  Fig. 1a ). In contrast to ACHN and Hela cells control and transduced MiaPaCa2 cells showed very similar S-phase statistics with 18.8%, 19.1% and 20.5% S-phase cells ( Supplementary Fig. 2a ).
Characterization of the subcellular localization of pp32r1 and pp32r1Y140H proteins by confocal microscopy
The structural and functional differences between the ANP32 family members (ANP32A-H) are still unclear, however the cellular localization of individual family members has been attributed to a Nuclear localization sequence (NLS) at the extreme C-terminal of the protein in some family members [6, 4] . In pp32r1 (ANP32C) the NLS appears incomplete with only the residues KRK at the C-terminus, we therefore sought to determine and compare the cellular localization of pp32r1 and the pp32r1Y140H mutant protein. We performed Confocal Laser Scanning Microscopy (CLSM) on HEK293T cells transiently overexpressing C-Terminal GFP tagged pp32r1 and pp32r1Y140H constructs. The localization of both pp32r1 and mutant proteins was observed to be predominantly cytoplasmic and is shown in Fig. 3 . To further confirm these results, we performed immunofluorescence microscopy on our ACHN cell lines stably overexpressing pp32r1 and pp32r1Y140H. Since the protein sequences for pp32 and pp32r1 are~87% identical we first checked by ELISA (using recombinant bacterially produced pp32 proteins) that the commercial antibodies against pp32 and pp32r1 were specific ( Supplementary Fig. 3A ). The pp32r1 antibody was highly specific and able to react with pp32r1 and pp32r1Y140H proteins but showed no reactivity toward pp32 protein. We then performed immunofluorescence with the pp32r1-specific antibody on fixed cells using DAPI as a nuclear stain. Although staining was quite weak it could clearly be seen that the expression pattern of pp32r1 and the pp32r1Y140H proteins was predominantly cytoplasmic ( Supplementary Fig. 3B ). Additional western blotting of cytoplasmic and nuclear extracts ( Supplementary Fig. 3C ) demonstrated that both pp32r1 and pp321Y140H are predominantly cytoplasmic, in contrast to the known nuclear/cytoplasmic shuttling seen with pp32 [14] .
Proteome analysis -ICPL strategy
We sought to identify potential differences between the three cell lines that could explain the altered proliferative capacity and cell cycle changes by performing a comprehensive proteomic analysis using an ICPL strategy (Full quantitated ICPL results are given in Supplementary Excel Table 1 ). From these mass spectrometry data we were able to identify a number of proteins that show a significant regulation (> 40%) relative to the wild type ACHN cell line and these are listed in Table 1 . The CAPG and CHD4 proteins showed more than 1.5 fold upregulation and were selected to validate the results of the ICPL by QRTPCR and western blotting.
Regulation of CAPG and CHD4 expression in ACHN cell lines transduced with pp32r1 or the Y140H mutant
To confirm the regulation of expression for the CAPG and CHD4 proteins that were shown to be upregulated in our ICPL results we assessed the mRNA levels by qRT-PCR using Taqman assays and protein levels by western blotting of cell lysates. At the mRNA level no significant changes in the mRNA levels of either the CAPG or CHD4 genes were observed in the transduced cell lines (Fig. 4a) . In contrast western blotting of ACHN and transduced cell lysates with CAPG and CHD4 specific antibodies demonstrated that both proteins are upregulated (Fig. 4b ). CAPG upregulation was estimated from average band intensity values to be increased~1.6-fold for both pp32r1 and pp32r1Y140H lysates and was comparable with the ICPL data. The detection of endogenous CHD4 in untransduced cells proved difficult to detect, likely due to the low expression levels and poor blotting efficiency of the large 218Kda protein. This expression however became highly upregulated in cell lines overexpressing pp32r1 or the pp32r1Y140H proteins ( Fig. 4b) .
Increased CHD4 and p21 expression in the pp32r1/pp32r1Y140H transduced HeLa cell lines was also observed ( Supplementary Fig. 1b ). However in the MiaPaca2 cell lines which contain the common p53 R248W mutation all p53 dependent p21 expression is abolished, thus no detectable p21 by western blotting (Supplementary Fig. 2b ). In these cell lines CHD4 was difficult to detect due to low endogenous levels, however slight increases were also observed in cells expressing pp32r1 and pp32r1Y140H proteins ( Supplementary Fig. 2b ).
Delineation of the CHD4 pathway mediating the G1/S phase dysregulation
CHD4 has been shown to play a major role in the coordination of the DNA Damage Response (DDR) and its expression level appears to be a critical regulator of the G1/S transition phase of the cell cycle through its influence on the p53-p21 axis of the cell cycle [15] . We therefore compared ACHN, ACHN pp32r1 and pp32r1 mutant overexpressing cell lines to ascertain if there were differences at the mRNA and protein levels for the cell cycle regulatory genes; retinoblastoma (Rb)/phosphorylated retinoblastoma (P-Rb), Acetylated p53 (p53Ac), p21, cyclinD1 and cyclinE. From Fig. 5b, p21 and cyclinD1 showed an increase, p53Ac a decrease and cyclinE, retinoblastoma (Rb), phosphorylated retinoblastoma (P-Rb) no difference in protein levels. At the RNA level, while p53 showed no difference in levels, p21 was downregulated (Fig. 5a) 
CHD4 shRNA mediated knockdown
We have shown that CHD4 is upregulated as a result of the overexpression of pp32r1Y140H ( Fig. 4b ) and that prominent cell cycle regulatory genes were subsequently affected ( Fig. 5b) . We next performed knockdown of CHD4 using shRNA containing vectors to determine if the increase in CHD4 was indeed the main cause of the observed G1/S phase dysregulation in the ACHN pp32r1Y140H cell line. Cells were transfected with shRNA containing vectors specific for CHD4, selected with puromycin and compared to empty vector and shRNA-scramble (scr) controls. We observed a knockdown of~50% with shRNA# 1 and~48% with shRNA#1 + #2 combined, compared to the shRNA-scrambled control ( Supplementary Fig. 4a ). Subsequent PI based cell cycle analysis of the CHD4 knockdown cells showed a significant reduction in the S phase by~80% and appears to revert the cell cycle profile of pp32r1Y140H over-expressing cells to that of the untransduced ACHN cell line ( Supplementary Figs. 4b  and 2 ). We again checked the mRNA and protein levels of retinoblastoma (Rb)/phosphorylated retinoblastoma (P-Rb), Acetylated p53 (p53Ac), p21, cyclinD1 and cyclinE across the four ACHN pp32r1Y140H transfected cell linesvector, scrambled, shRNA#1 and shRNA#1+#2 combined. As seen in Fig. 6b , reduced CHD4 protein levels corresponded to a concomitant increase in p53Ac382 levels; however, p21 levels still remained elevated despite the CHD4 knockdown. At the mRNA level (Fig. 6a) , negligible change was seen in case of p53, while p21 showed decreased levels. This trend has previously been reported in other transformed cell lines [16] .
Discussion
The pp32 (ANP32A) protein acts as a tumor suppressor while its closely related homologue pp32r1 (ANP32C) exhibits an opposing function by acting as an oncogenic mediator. In this study we sought to fully characterize the effects of overexpressing pp32r1 or its functional mutant pp32r1Y140H in several cancer cell lines.
The pp32 protein sequence contains a Nuclear Localization Signal (NLS) and is predominantly localized in the nucleus, although it has been recently shown to shuttle between nucleus and cytoplasm alongside HuR [14] . In contrast the sequence of pp32r1 (and its mutant) contains an incomplete NLS, which suggested cytoplasmic localization. To confirm this we performed both Fluorescence microscopy on HEK293T cells transiently overexpressing C-Terminal GFP tagged pp32r1 and pp32r1Y140H constructs ( Fig. 3) as well as Immunofluorescence microscopy on the over-expressing ACHN cell lines using a pp32r1 specific antibody ( Supplementary Fig. 2 ). The observed differential localization between pp32 and pp32r1 would suggest alternate interaction partners and resulting downstream effects and is likely to be one factor that influences the diametrically opposing functions of these proteins as either tumor suppressor or oncogene respectively. We cannot however exclude the possibility that nuclear pp32r1 or pp32r1Y140H might exist. However any nuclear pp32r1 would however rely on co-transport alongside endogenous levels of pp32r1 binding partners containing a bone-fide NLS sequence that is clearly absent in pp32r1.
Cells over-expressing pp32r1Y140H are known to have a significantly higher proliferation rate compared to control cells or cells over-expressing pp32r1 [3] . Growth assays demonstrated that overexpression of pp32r1 or pp32r1Y140H mutant protein in the two p53 wt cell lines (ACHN and HeLa) showed pronounced increases in proliferation while in the transduced p53 R248W MiaPaCa2 cell lines no difference in cell growth was observed (Fig. 1b ). The cell growth differences observed for ACHN cells were much more prominent than in HeLa cells. We hypothesize that this is likely to be determined by the normal cell doubling time of the untransduced ACHN (28-30 h) and HeLa (23-24 h) cell lines. While the transduced ACHN cell lines are able to accelerate their growth more toward the limit of cell doubling time, HeLa cells are already an extremely fast growing cell line very close to their cell doubling time limit. The observation that MiaPaCa2 cell growth was not affected highlighted a possible influence on the p53-p21 axis of the cell cycle since the common p53 R248W mutation abolishes p53 dependent p21 expression. Although it is possible that mutations in other genes could play a role in modulating the pp32r1 induced proliferative capacity of cells, these data strongly suggested that influence on p53 induced p21 expression might be the predominant cause. We investigated further both the cell cycle and proteomic differences in our ACHN cell lines. Cell cycle analysis of total DNA content (PI staining) demonstrated a 2 fold increase in the S phase of pp32r1Y140H over-expressing cells when compared to control or pp32r1 expressing cells (Fig. 2a,c,e) . A comparative quantification of the cells in S phase using the BrdU incorporation assay confirmed these data and we observed a 2 fold increase in the percentage of S phase cells over-expressing the pp32r1Y140H mutant compared to untransduced cells (Fig. 2b, d, f) . These results suggested that the increase in cell proliferation observed in the pp32r1Y140H mutant was due to a dysfunctional control over the G1/S transition phase of the cell cycle.
To understand the effects of pp32r1 and pp32r1Y140H overexpression on the cell proteome we performed mass spectrometry based whole proteome profiling on our 3 ACHN cell lines using the ICPL technique. A total of 129 differentially regulated proteins were identified with respect to control or pp32r1 transduced cells from which we selected 13 highly regulated (>40%) proteins (Table 1) . Several of the proteins we identified using the ICPL strategy have attributed oncogenic roles and dysregulation can lead to Epithelial to Mesenchymal transition (EMT), metastasis, multi drug resistance, cell survival signalling, DNA repair, cell cycle regulation and overall poor prognosis of cancer inflicted patients, a full description of the oncogenic roles for all of these proteins is provided ( Supplementary ICPL proteins.doc) .
The CAPG and CHD4 proteins showed more than 1.5 fold upregulation and were selected to validate the results of the ICPL by QRTPCR and western blotting. The mRNA levels of both CHD4 and CAPG were found to be unaffected across the 3 ACHN cell lines; however the protein levels of CHD4 and CAPG were found to be upregulated in accordance with the ICPL data.
Macrophage Capping protein (CapG), a member of the gelsolin superfamily of actin-binding proteins, which are crucial for the organization of the actin cytoskeleton. The actin cytoskeleton underlies many cellular functions including the maintenance and mutability of cell shape, motility, adherence, and growth regulation. Dysregulation of actin-based motility is a prominent factor in cell transformation and has been associated with carcinogenesis. Experimental evidence shows that CapG known to be crucial for regulating cell motility possesses an oncogenic function involved in the control of cell migration or invasion [17] . Significant over expression of CapG was detected in Oral Squamous Cell Carcinomas (OSCCs), Endometrial carcinoma (EmCa), Pancreatic Ductal Carcinoma, Prostate cancer through immunohistochemical, LC-MS/MS, 2-DE/MS studies. Thus, enhanced expression of CapG has been associated with malignancy, increased tumor size and reduced survival [17] [18] [19] [20] .
Chromodomain Helicase DNA binding protein 4 (CHD4) functions in the coordination of DNA Damage Response (DDR) by mediating rapid poly (ADP-ribose) dependent recruitment of the NuRD complex to DNA damage sites [21] . Knockdown studies and BrdU incorporation assays demonstrated a specific role of CHD4 in cell cycle progression, in particular as a critical regulator of the G1 to S (G1/S) transition through the control of p53 deacetylation [21, 22] . This role of CHD4 further corroborated our observation of an elevated S phase in pp32r1 and pp32r1 Y140H over expressing cells.
The elevated levels of CHD4 and S phase cells caused by pp32r1 or pp32r1Y140H over-expression suggested that CHD4 control of the G1/S transition phase of the cell cycle had been dysregulated. The major role of CHD4 is in the coordination of the DNA Damage Response (DDR) however it is also known to influence the p53-p21 axis of the cell cycle, that acts as the master regulator of the G1/S phase transition through p53 stabilization (via Lys-382 acetylation) and subsequent induction of p53 dependent p21 transcription [15] . We therefore compared the cell cycle profiles and the levels of the G1/S phase cell cycle checkpoint proteins Rb, p53, p21, cyclinE and cyclinD1, across ACHN, ACHN pp32r1/pp32r1Y140H and CHD4 knockdown cells by western blotting. In cell lines overexpressing pp32r1 or pp32r1Y140H we observed no difference in the levels of Rb or CyclinE, while significant increases were detected in CHD4 and p21 protein levels (Table 1 and Figs. 4b and 5b ). In contrast there was a modest decrease in the level of acetylated p53 (p53Ac382, stabilized form of p53).
CHD4 shRNA mediated knockdown in pp23r1Y140H overexpressing cells demonstrated an approximate 80% reduction in S phase cells thereby reverting the cell cycle profile to that of the untransduced ACHN cells and confirming the relevance of CHD4 in mediating the G1/S phase dysregulation in pp32r1Y140H overexpressing cells. As predicted reduced CHD4 protein levels in CHD4 knockdown cells corresponded to a concomitant increase in p53Ac382 levels, however, p21 levels still remained elevated despite the CHD4 knockdown ( Fig. 6b) . At the mRNA level, negligible differences were seen in case of p53. However, both of the transduced pp32r1/pp32r1Y140H overexpressing cell lines showed decreased p21 levels with respect to ACHN. Similar RNA profiles for p53 and p21 were obtained in CHD4 knockdown cells when compared with the vector and scrambled controls ( Figs. 5a and 6a) .
The increased levels of p21 protein observed in our pp32r1 and pp32r1YH overexpressing cell lines are consistent with clinical data. Elevated levels of p21 expression have been detected in gliomas, non small cell lung carcinomas, invasive cervical cancer, bladder carcinomas as well as malignantly transformed cell lines. In these instances p21 contributes to a post-transcriptional and p53 independent mechanism of cell proliferation that is mediated via cyclinD1 stabilization [39, 23] . This is contrary to the assumption that cyclin-dependent kinase inhibitors (CKIs) like p21 are solely negative regulators of cyclin-dependent kinases (CDKs) and can only contribute to cell cycle arrest. Interestingly, they can also be found in complexes with active cyclin-CDKs allowing them to act as positive regulators of the cell cycle [24] . Indeed p21 is an essential activator of CDK4 and can increase the assembly and stability of active cyclinD1-CDK4 complexes by promoting their localization to the nucleus [41] . The increased levels of cyclinD1 and p21 in the ACHN pp32r1, and ACHN pp32r1 Y140H cell lines appears consistent with the findings of Coleman et al. who demonstrated that Ras transformed fibroblasts contain elevated levels of p21 and cyclinD1 and that p21 is responsible for stabilization and prevention of cyclinD1 degradation by the 20S proteasome [24] . However, on silencing CHD4 in our ACHN pp32r1Y140H cell line the levels of p21 were further increased, whereas no differences were observed in the level of CyclinD1.
These increases in p21 have also been observed in the work of Polo et al. where CHD4 knockdown in U2OS cells resulted in a rapid accumulation of p21 protein that was restricted to p53 containing cells [15] . In these cells increases in p21 were accompanied by higher p53 protein levels and increased binding of p53 to the p21 promoter. Our CHD4 knockdown cells also illustrate increases in p53Ac382 and p21, presumably like in U2OS cells where p53-dependent transcriptional regulation of p21 occurs as a result of DNA damage accumulation in CHD4 knockdown cells. In our ACHN and transduced cell lines a constant level of cyclinE was observed ( Figs. 5b and 6b ).This appears inconsistent with the notion that p21, when is present above a certain threshold, can negatively regulate cyclinE/Cdk2, resulting in lower levels of cyclinE [25] . In our cell lines the negative regulation caused by an increase in p21 levels appears to be off set by its regulation of cyclinD1, leading to an over proliferative phenotype despite increased p21 expression levels.
In summary our data suggests that pp32r1 and its functional mutant Y140H can promote a CHD4 mediated cyclinD1 regulation that causes p21 protein stabilization and leads to a maintained proliferation of cells despite a dysregulation of the normal checkpoint control mechanisms. Although we have focused on the effects of the pp32r1Y140H mutation, further mutations exist in pp32r1 (e.g. E166G) identified in oral carcinoma [26] that appear to illustrate a similar phenotype. Although the prevalence of mutations in clinical cases is still unclear such a phenotype may have implications on patient treatment scenarios. Indeed we have also observed significant differences in the viability of pp32r1 or pp32r1 mutant cell lines in response to certain chemotherapeutic agents (Unpublished Observations).
The pp32 family proteins have functional roles in the essential cellular processes of transcription, mRNA export, apoptosis, and cell cycle regulation. These functional roles can be impaired as is seen by their involvement in both cancer [27] [28] [29] 7, 30] and neurodegenerative diseases like spinocerebellar ataxia type 1 [31] , highlighting the important role they play in maintaining cellular stability.
Supplementary data to this article can be found online at http:// dx.doi.org/10.1016/j.bbamcr.2013.02.001.
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